Full Press Release Details
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants.
GLUE
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Key Takeaway: Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Price reaction · baseline $16.01 (2026-01-06 close) · hit after-hours · 2 other GLUE headline(s) in the window, move may be shared
day 0 close
+45.4%
day 1 · peak
+58.1%
day 3
+48.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+67%
120-day peak, hindsight
Typical move
13.3%
average across 9 past catalysts
Cash runway
~41 mo
Minimal dilution risk
Lead asset
MRT-2359
Phase 2 · Castration-Resistant Prostate Cancer (CRPC)